Search Results - "Rosada, Cecilia"
-
1
Leptin deficiency in mice counteracts imiquimod (IMQ)‐induced psoriasis‐like skin inflammation while leptin stimulation induces inflammation in human keratinocytes
Published in Experimental dermatology (01-04-2017)“…Leptin is an adipocyte‐derived cytokine secreted mostly by adipose tissue. Serum leptin levels are elevated in obese individuals and correlate positively with…”
Get full text
Journal Article -
2
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells
Published in Nature biotechnology (01-06-2002)“…Human bone marrow stromal cells (hMSCs) were stably transduced by a retroviral vector containing the gene for the catalytic subunit of human telomerase…”
Get full text
Journal Article -
3
Psoriasiform skin disease in transgenic pigs with high-copy ectopic expression of human integrins α2 and β1
Published in Disease models & mechanisms (01-07-2017)“…Psoriasis is a complex human-specific disease characterized by perturbed keratinocyte proliferation and a pro-inflammatory environment in the skin. Porcine…”
Get full text
Journal Article -
4
Interleukin-20 as a Target in Psoriasis Treatment
Published in Annals of the New York Academy of Sciences (01-09-2007)“…: Interleukin‐20 (IL‐20) is a new member of the IL‐10 cytokine family discovered by a structural algorithm. IL‐20 transgenic mice displayed skin abnormalities…”
Get full text
Journal Article -
5
Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo
Published in Dermatology reports (17-12-2015)“…Acne is a common skin disease involving colonization with Propionibacterium acnes (P. acnes), hyperproliferation of the follicular epithelium and inflammatory…”
Get full text
Journal Article -
6
Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment
Published in Experimental dermatology (01-09-2017)“…TNFα‐, IL‐23‐ and IL‐17‐targeting drugs are highly effective in the treatment of psoriasis. However, the precise molecular mechanism remains unknown. In…”
Get full text
Journal Article -
7
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
Published in Life science alliance (01-05-2023)“…The p90 ribosomal S6 kinases (RSKs) contain two distinct catalytic kinase domains, the N-terminal and C-terminal kinase domains (NTKD and CTKD, respectively)…”
Get full text
Journal Article -
8
Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model
Published in Molecular therapy (01-10-2009)“…Tumor necrosis factor-α (TNF-α) is upregulated in psoriatic skin and represents a prominent target in psoriasis treatment. The level of TNF-α-encoding mRNA,…”
Get full text
Journal Article -
9
Langerhans cell markers CD 1a and CD 207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment
Published in Experimental dermatology (01-09-2017)“…Abstract TNF α‐, IL ‐23‐ and IL ‐17‐targeting drugs are highly effective in the treatment of psoriasis. However, the precise molecular mechanism remains…”
Get full text
Journal Article -
10
Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms
Published in The American journal of pathology (01-10-1996)“…The cell surface glycoprotein CD44 is expressed primarily in the region of cell replication in the lower crypt epithelium of colorectal mucosa, and its…”
Get full text
Journal Article -
11
Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model
Published in Acta dermato-venereologica (01-01-2014)“…Debio 0932 is a novel oral heat shock protein 90 (Hsp90) inhibitor developed for anti-cancer therapy. Surprising-ly, during the first clinical trial, one…”
Get full text
Journal Article -
12
Resolution of Psoriasis by a Leukocyte-Targeting Bacterial Protein in a Humanized Mouse Model
Published in Journal of investigative dermatology (01-10-2011)“…Psoriasis is a very common chronic skin disease, affecting 2–3% of the world's population or more than 125 million individuals worldwide. The characteristic…”
Get full text
Journal Article -
13
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model
Published in Protein engineering, design and selection (01-10-2015)“…Targeting more than one molecule in multifactorial diseases involving several disease mediators may provide improved therapeutic efficacy. Psoriasis is a…”
Get full text
Journal Article -
14
Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model
Published in Journal of investigative dermatology (01-02-2010)“…Valrubicin is a cytostatic drug currently approved by the American Federal Drug Administration as a trademarked Valstar sterile solution for the treatment of…”
Get full text
Journal Article -
15
A lentiviral vector-based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin
Published in Experimental dermatology (01-03-2013)“…Vitamin D3 analogues are widely used topical and oral remedies for various ailments such as psoriasis, osteoporosis and secondary hyperparathyroidism. In…”
Get full text
Journal Article -
16
Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases
Published in Journal of drugs in dermatology (01-10-2013)“…Valrubicin is a semisynthetic anthracycline developed as an anti-cancer drug able to ameliorate psoriasis and non-melanoma skin cancer (NMSC) by topical…”
Get more information
Journal Article -
17
-
18
Topical application of valrubicin has a beneficial effect on developing skin tumors
Published in Carcinogenesis (New York) (01-08-2010)“…Valrubicin is a second generation anthracycline characterized by an excellent safety profile presenting no skin toxicity or necrosis upon contact. In its…”
Get full text
Journal Article -
19
Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A
Published in Experimental dermatology (01-05-2011)“…: Psoriasis xenograft transplantation models where human skin is transplanted onto immune‐deficient mice are generally accepted in psoriasis research. Over…”
Get full text
Journal Article -
20
Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human Skin
Published in Human gene therapy. Part B. Methods (01-08-2015)“…Skin is an easily accessible organ, and therapeutic gene transfer to skin remains an attractive alternative for the treatment of skin diseases. Although we…”
Get more information
Journal Article